Infusion pump

Healthcare IT Market worth $829.2 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, August 25, 2021

By product and services type segment, the healthcare provider solutions segment accounted for the largest market share during the forecast period.

Key Points: 
  • By product and services type segment, the healthcare provider solutions segment accounted for the largest market share during the forecast period.
  • Based on products and services, the healthcare IT market has been segmented into healthcare provider solutions, healthcare payer solutions and HCIT outsourcing services.
  • Clinical healthcare IT solutions accounted for the largest market share in the healthcare provider solutions segment during the forecast period.
  • In the healthcare provider solutions segment, clinical healthcare IT solutions accounted for the largest market share during the forecast period.

Healthcare IT Market worth $829.2 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, August 25, 2021

By product and services type segment, the healthcare provider solutions segment accounted for the largest market share during the forecast period.

Key Points: 
  • By product and services type segment, the healthcare provider solutions segment accounted for the largest market share during the forecast period.
  • Based on products and services, the healthcare IT market has been segmented into healthcare provider solutions, healthcare payer solutions and HCIT outsourcing services.
  • Clinical healthcare IT solutions accounted for the largest market share in the healthcare provider solutions segment during the forecast period.
  • In the healthcare provider solutions segment, clinical healthcare IT solutions accounted for the largest market share during the forecast period.

$94.2 Bn IoT Medical Devices Markets: Blood Pressure Monitor, Glucometer, Cardiac Monitor, Pulse Oximeter, Infusion Pump - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 24, 2021

Based on product, the IoT medical devices market has been segmented into vital signs monitors, imaging systems, implantable cardiac devices, patient monitors, respiratory devices, infusion pumps, neurological devices, anesthesia machines, ventilators, and hearing devices.

Key Points: 
  • Based on product, the IoT medical devices market has been segmented into vital signs monitors, imaging systems, implantable cardiac devices, patient monitors, respiratory devices, infusion pumps, neurological devices, anesthesia machines, ventilators, and hearing devices.
  • By connectivity technology, the Wi-fi based medical devices segment accounted for the largest share of the IoT medical devices market in 2020.
  • Based on connectivity technology, the global IoT medical devices market is segmented into Bluetooth, Wifi, and Zigbee based medical devices.
  • Wi-Fi based medical devices accounted for the largest share in the IoT medical devices market.

Global Infusion Pumps and Accessories Market to 2027 - Increasing Use of Infusion Pumps In-Home Care Settings Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, August 13, 2021

According to this report the infusion pumps and accessories global market is expected to grow at mid single digit CAGR from 2020 to 2027, to reach $14,886.0 million by 2027.

Key Points: 
  • According to this report the infusion pumps and accessories global market is expected to grow at mid single digit CAGR from 2020 to 2027, to reach $14,886.0 million by 2027.
  • The increasing trend for wireless infusion pumps, increased use of smart pumps, and market expansion in emerging nations are expected to offer potential opportunities.
  • However, various factors such as patient safety risks and medication errors associated with infusion pumps, an increasing number of infusion pumps product recalls are limiting the growth of infusion pumps and accessories global market.
  • The threats for the infusion pumps and accessories market include lack of cyber-security in wireless infusion pumps and stringent regulatory requirements for the development and approval of new products.

IHS Announces CE Mark Certification for Proprietary Syringe Infusion System

Retrieved on: 
Thursday, July 22, 2021

Innovative Health Sciences, LLC (IHS or the Company) announced today that they have received ISO 13485 quality management system and CE mark certification for the Insignis Syringe Infusion System.

Key Points: 
  • Innovative Health Sciences, LLC (IHS or the Company) announced today that they have received ISO 13485 quality management system and CE mark certification for the Insignis Syringe Infusion System.
  • The CE mark, abbreviated for European Conformity ("Conformit Europene"), enables IHS to sell the system throughout the European Union.
  • The Insignis Syringe Infusion System is the first combination of intravenous and subcutaneous non-electric infusion pump created for use with a selectable rate flow controller, the IV Controller and the OneSett.
  • The IHS infusion system addresses nearly every infusion therapy need and can support intermittent, pause dosing, ideal for lengthy low-volume hospital infusions.

Virtis Health Unveils Three Ambulatory Infusion Centers in Arizona, Bringing Total to Seven

Retrieved on: 
Tuesday, July 20, 2021

This expansion brings the total number of Virtis Health AICs to seven statewide.

Key Points: 
  • This expansion brings the total number of Virtis Health AICs to seven statewide.
  • View the full release here: https://www.businesswire.com/news/home/20210720005314/en/
    A Virtis Health nurse practitioner provides infusion therapy to a patient in the Company's new Flagstaff, AZ Ambulatory Infusion Center.
  • Our Virtis Health Arizona infusion centers offer patients greater privacy and a place where they can comfortably and easily receive specialty infusible and injectable medications.
  • Additionally, Virtis Health provides comprehensive infusion center and related practice management services to physicians, health systems and other medical entities nationwide.

Outlook on the Infusion Pumps Global Market to 2025 - Rapid Adoption of Home Infusion Pump Therapies is Driving the Industry - ResearchAndMarkets.com

Retrieved on: 
Friday, June 25, 2021

The global infusion pumps market is expected to record a value of US$18.80 billion in 2025, progressing at a CAGR of 7.34%, for the duration spanning 2021-2025.

Key Points: 
  • The global infusion pumps market is expected to record a value of US$18.80 billion in 2025, progressing at a CAGR of 7.34%, for the duration spanning 2021-2025.
  • The global infusion pumps market can be segmented on the basis of type, product, technology, application and end-user.
  • Based on type, the market can be bifurcated into volumetric pumps, ambulatory pumps, syringe pumps, enteral pumps, Patient Controlled Analgesia (PCA) pumps, implantable pumps and pump accessories.
  • In terms of application, the global infusion pumps market can be split into chemotherapy, gastroenterology, analgesia, diabetes, pediatric & neonatology and other applications.

Global Home Infusion Therapy Market Size, Share & Trends Analysis Report 2021-2028: Products (Infusion Pumps, Needleless Connectors), Application (Anti-infective, Chemotherapy) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 5, 2021

b'The "Home Infusion Therapy Market Size, Share & Trends Analysis Report by Product (Infusion Pumps, Needleless Connectors), by Application (Anti-infective, Chemotherapy), by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global home infusion therapy market size is expected to reach USD 44.7 billion by 2028.

Key Points: 
  • b'The "Home Infusion Therapy Market Size, Share & Trends Analysis Report by Product (Infusion Pumps, Needleless Connectors), by Application (Anti-infective, Chemotherapy), by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global home infusion therapy market size is expected to reach USD 44.7 billion by 2028.
  • It is expected to expand at a CAGR of 8.5% from 2021 to 2028.\nHome infusion therapy involves the intravenous or subcutaneous administration of drugs or biological products to an individual at home.
  • Favorable government policies and regulations are expected to propel market growth.
  • Moreover, patients who seek infusion therapy already have diseases that weaken their immune systems.

Smiths Medical and Ivenix Partner to Revolutionize Infusion Management with First-Ever Comprehensive Suite of Infusion Solutions in US Healthcare Market

Retrieved on: 
Tuesday, May 4, 2021

Ensuring patient safety and clinical efficiency are critical components of successful life-saving infusion management.

Key Points: 
  • Ensuring patient safety and clinical efficiency are critical components of successful life-saving infusion management.
  • For more information, visit www.smiths-medical.com .\nIvenix, Inc. is a medical technology company with a vision to eliminate infusion-related patient harm.
  • Ivenix designed an infusion system from the ground up to streamline medication delivery and bring infusion technology into the digital age.
  • The Ivenix Infusion System includes a large-volume infusion pump supported by a robust infusion management system designed to set new standards in simplicity, intelligence, and reliability.

Analytica Announces Expansion of Enhanced Infusion System into Middle East

Retrieved on: 
Tuesday, April 27, 2021

The EIS reacts immediately, silently and without intervention or programming.

Key Points: 
  • The EIS reacts immediately, silently and without intervention or programming.
  • It can be retrofitted to any existing infusion system design and can work in harmony with and improve the capability of any infusion pump or \xe2\x80\x98bag\xe2\x80\x99 infusion system, regardless of sophistication.\nUse of the EIS uniquely allows a completely closed infusion system, with integrity achieved by reducing the interactions believed to cause mechanical and vascular complications as well as good flushing and/or patency practice.\nThe EIS has an Australian TGA ARTG registration and USFDA 510(k) clearance.
  • EIS limits access and infection opportunity.\nFlushing pressure \xe2\x80\x93 Bolus flush of catheter may vary based on syringe size and pressure.
  • This affects 1 in 3 women worldwide and is mostly caused by trauma to the pelvic floor muscles because of pregnancy, childbirth and menopause.\n\xc2\xb9 Trademark of ICU Medical Australia.\n'